Glucose Health, Inc.
GLUCNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for GLUC. That does not mean none is planned.
Get an email about GLUC's next catalysts
Track Glucose Health (GLUC) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
Market Overview
Stock performance and key metrics
No drugs found in this phase.
HR+/HER2− metastatic breast cancer
1 drug in this indication
Type 2 Diabetes management
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
When is Glucose Health, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Glucose Health, Inc. (GLUC) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track GLUC biotech catalysts?→
Add GLUC to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Glucose Health, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.